ABSTRACT
INTRODUCTION
Noonan syndrome is an autosomal dominant congenital abnormality having an incidence of between 1 : 1000 and 1 : 2000 in the general population 1, 2 . The gene responsible for the defect has recently been located to the short arm of chromosome 12 [3] [4] [5] . It is characterized by dysmorphic facies, webbed neck, short stature, cardiac anomalies and varying degrees of mental retardation, as well as abnormalities of the lymphatic system. Diagnosis of Noonan syndrome is often only confirmed clinically during the late childhood years; prenatal diagnosis of the syndrome is complicated by the nature of its associated anomalies 6, 7 . While the association between Noonan syndrome and lymph system abnormalities is well-established [8] [9] [10] [11] [12] [13] [14] , during prenatal life, the condition may manifest in many forms, ranging from increased localized cervical spine findings, such as cystic hygroma, to generalized lymph edema as seen in nonimmune hydrops fetalis 9, 10, [15] [16] [17] [18] [19] . The severity of these conditions varies widely among patients and has been found to progress in some cases with gestation and the neonatal period and beyond 1, 6, 7, 11, 12 . The webbed neck often observed in Noonan patients probably represents resolving cervical cystic hygroma.
The hydrops fetalis described in Noonan syndrome probably represents the severe end of the spectrum of lymph pathology, but may also result from a cardiac dysfunction sequence 15 . Congenital heart disease may appear in up to 60% of Noonan syndrome patients 6,7,11,20 -24 . In fact, cardiac abnormality associated with cervical lymphatic abnormalities may provide the only clues to a diagnosis of Noonan syndrome. Numerous and varied cardiac abnormalities have been described in Noonan syndrome; some are more specific to the syndrome, while others are less so.
As the prenatal diagnosis of congenital heart defects is crucial for the diagnosis of Noonan syndrome in utero , we set out to review the current literature on prenatal detection of cardiac anomalies in cases diagnosed with Noonan syndrome.
METHODS
We conducted an English-language literature search in the 'Medline' listing, and reviewed those cases of postnatally Correspondence: Prof. Simcha Yagel, Department of Obstetrics and Gynecology, Hadassah University Hospital, Mt Scopus, PO Box 24035, Jerusalem, Israel (e-mail: syagel@hadassah.org.il) Ultrasound in Obstetrics and Gynecology confirmed Noonan syndrome that were examined by prenatal ultrasound. In addition, we included four cases of the syndrome diagnosed at our center.
RESULTS

Case reports
Case 1
A 31-year-old, gravida 2, para 1, was referred for a mid-trimester scan at 20 weeks of gestation, which was normal. Followup at 28 and 34 weeks for suspected intrauterine growth restriction showed no visible abnormality and a normal amniotic fluid volume. The woman delivered at term a male newborn with features of Noonan syndrome and hypertrophic cardiomyopathy.
Case 2
A 22-year-old gravida 1, para 0, who had a normal scan at 20 weeks of gestation, presented for a routine fetal growth assessment at 34 weeks. Mild pulmonary stenosis was identified. The patient delivered a term female; at the age of 5 years, mild pulmonary stenosis and classic features of Noonan syndrome were evident.
Case 3
A 41-year-old gravida 4, para 3, had normal 16-week and 21-week targeted organ scans, and a 34-week fetal growth assessment scan. She delivered a male newborn at term; at the age of 5 years, echocardiography was performed as part of an investigation of short stature and mild mental retardation. Echocardiography revealed mild to moderate pulmonary stenosis and a diagnosis of Noonan syndrome was made.
Case 4
A 23-year-old gravida 2, para 1, who had a normal targeted organ scan at 22 weeks of gestation, was referred for suspected macrosomia at 35 weeks for a fetal growth assessment scan. Pulmonary and aortic stenosis and ventricular hypertrophy were identified. The patient delivered a male at term. Prenatal ultrasound findings were confirmed postnatally by echocardiography. Table 1 summarizes the current published cases of Noonan syndrome in which prenatal ultrasound examination was performed. The cases are presented in chronological order according to their description in the English-language literature. The last four cases included are those diagnosed in our center. The following criteria were analyzed: (i) cervical spine pathologies; (ii) cardiac anomalies; and (iii) other pathological findings, including hydrops fetalis and polyhydramnios.
Of the 33 cases described here, 19 had polyhydramnios and eight developed hydrops fetalis. Manifestation of cervical pathology was evident in only 14 cases, of which three were diagnosed in the first trimester (including one isolated with increased nuchal translucency). Nine cases of cystic hygroma were diagnosed at midtrimester. Cardiac anomalies were suspected in only nine cases, three of which were reported to be associated with cystic hygroma. All of these cardiac anomalies were confirmed (at least in part) postnatally by echocardiography or by post mortem.
Postnatally, the following cardiac anomalies were diagnosed: ventricular hypertrophy or other cardiomyopathy ( n = 13); pulmonary stenosis or dysplasia ( n = 13); aortic stenosis ( n = 3); ventricular septal defect ( n = 5); atrial septal defect ( n = 3); atrioventricular valve anomalies ( n = 3); coarctation of the aorta ( n = 1); atrioventricular canal ( n = 1); and tetralogy of Fallot ( n = 1). In seven cases, more than one cardiac anomaly was diagnosed.
DISCUSSION
In this review, we have summarized cases diagnosed with Noonan syndrome in which prenatal ultrasound examination was performed. The most common prenatal features of Noonan syndrome are polyhydramnios (19/33), cervical pathologies (cystic hygroma, skin edema or nuchal translucency, 14/33), pleural effusion and hydrops fetalis (11/33). Heart malformations were evident prenatally only in nine cases (27%) of this group. The various cardiac anomalies described here concur with the large series described by Burch et al . 20 . Pulmonary valve anomalies (dysplastic or stenotic) and hypertrophic cardiomyopathy are the most common cardiac malformations, with an incidence ranging from 37.5% to 39% in both groups. However, unlike the Burch series, approximately 94% (31/33) of cases discussed here were diagnosed postnatally with cardiac anomalies compared to only 60% of their series. This discrepancy may be explained by the early postnatal follow-up of the cases described in this review. Subtle Noonan cases without cardiac malformation are probably diagnosed later in childhood; cases with cardiac malformation are more readily subjected to thorough diagnostic examination, leading to the diagnosis of Noonan syndrome at an earlier stage in neonatal life.
Analysis of the heart malformations associated with Noonan syndrome may explain the inability to diagnose them more effectively at the prenatal stage. Pulmonary stenosis and hypertrophic cardiomyopathies are typical examples of later onset cardiac malformations, which may appear during the third trimester of pregnancy or even after birth. Moreover, these anomalies may evolve or progress during pregnancy or early childhood from a mild to a severe phenotype of the disease, making diagnosis in utero impossible 25 -28 . Although 'lymphatic system' abnormalities (e.g. cystic hygroma, skin edema, pleural effusion and hydrops fetalis) are typical features of Noonan syndrome, they are of variable degrees of severity, nonspecific 9, 10, [15] [16] [17] [18] and manifest at varying stages of pregnancy. Thus, the identification of lymphatic system anomalies calls for thorough targeted organ screening, including fetal echocardiography and karyotyping, but these are far from being diagnostic of Noonan syndrome.
Prenatal detection of Noonan syndrome
Menashe et al. In conclusion, the poor detection rate of Noonan syndrome in utero and, specifically, the dismal diagnostic ability of its associated cardiac anomalies is explained by the nonspecific, variable, late onset and progressive nature of the disease, which is only fully manifest after birth.
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